Internal Medicine, Pulmonary Disease · Davenport, IA
NPI
1104891704
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
3385 Dexter Ct Ste 102
Davenport, IA, 52807
Phone (563) 323-1352
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
334 services
Medicare patients, 2024
292
Average age 73
Drug cost, 2024
$634K
2,973 prescriptions
Company payments, 2025
$34.71
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Akshay K Mahadevia was code 99213 (office e&m - established), 142 times for 133 patients. In total Akshay K Mahadevia billed 334 services in 7 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 142 | 133 | $45.46 | $6,455 |
| 95811 Sleep Study | Facility | 79 | 79 | $84.49 | $6,675 |
| 95800 Sleep Study | Facility | 59 | 59 | $25.38 | $1,498 |
| 95810 Sleep Study | Facility | 29 | 28 | $79.31 | $2,300 |
| 99214 Office E&M - Established | Facility | 21 | 21 | $66.37 | $1,394 |
By year: 2022 $66K for 1,248 services; 2023 $43K for 825 services; 2024 $19K for 334 services.
Medicare prescription drug claims, 2024
In 2024, the drug Akshay K Mahadevia prescribed most often to Medicare patients was Clonazepam, with 474 prescriptions and refills. In total Akshay K Mahadevia wrote 2,973 Medicare prescriptions that cost $634K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clonazepam Generic | 474 | 585 | 79 | $2,979 |
| Zolpidem Tartrate Generic | 437 | 489 | 69 | $2,812 |
| Temazepam Generic | 397 | 425 | 58 | $3,630 |
| Trazodone Hcl Generic | 261 | 357 | 49 | $1,596 |
| Ropinirole Hcl Generic | 154 | 283 | 33 | $3,812 |
| Lorazepam Generic | 121 | 125 | 17 | $665 |
| Eszopiclone Generic | 111 | 124 | 18 | $4,418 |
| Alprazolam Generic | 102 | 110 | 15 | $400 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 101 | 150 | 19 | $1,769 |
| Zaleplon Generic | 76 | 102 | 14 | $1,889 |
| Methylphenidate Hcl Generic | 73 | 73 | 16 | $3,191 |
| Triazolam Generic | 55 | 64 | Under 11 | $7,507 |
| Quetiapine Fumarate Generic | 52 | 54 | Under 11 | $358 |
| Belsomra Suvorexant | 35 | 43 | Under 11 | $19K |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 35 | 40 | Under 11 | $1,570 |
Brand drugs: 240 claims; generic drugs: 2,733 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Akshay K Mahadevia $34.71 ($34.71 in general payments such as food, travel and fees) from 2 companies. The largest payer was Resmed Corp with $18.67.
| Company | Payments | Amount |
|---|---|---|
| Resmed Corp RMD | 1 | $18.67 |
| Itamar Medical Inc | 1 | $16.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.